Belgium Firm to Buy Epilepsy-Focused Biopharma Co. for $1.9B
Source: Streetwise Reports  (1/19/22)
Shares of Zogenix Inc. rose by 66% after the company reported it entered into an agreement to be acquired by UCB. S.A. of Belgium for $26.00 per share in cash. The offer includes the potential for an additional $2.00 per share if a specific drug approval milestone is met. More >

Biotech Could Launch Trial of Polyp Screening Test in March
  (1/18/22)
The start of the C-Scan study would be a major milestone for Check-Cap, noted an H.C. Wainwright & Co. report. More >

Derm Biopharma Named Top Growth Pick For 2022
  (1/18/22)
Journey Medical should increase 2022 and 2023 revenue by at least 30% such that it could turn a profit in 2024, noted a ROTH Capital Partners report. More >

Why PennyQueen Likes This Energy Stock
Source: Penny Queen  (1/18/22)
PennyQueen explains why she thinks this uranium explorer is a great pick and why the metal should have an especially auspicious season. More >

Microsoft's Call of Duty to Buy Candy Crush for $69B
Source: Streetwise Reports  (1/18/22)
Shares of Activision Blizzard Inc. traded 26% higher after the developer and publisher of World of Warcraft® and Call of Duty® reported it agreed to be acquired by Microsoft Inc. for $95 per share in cash. More >

Uranium Price Forecast 2022, Growth Expected
Source: Streetwise Reports  (1/17/22)
Political unrest in Kazakhstan and a buildup of stockpiles is leading to tightened demand and opportunities for growth in uranium, according to an industry report. More >

Shades of Great Bear in Metals Creek
Source: John Newell  (1/17/22)
With two strong projects in a Tier One jurisdiction and experienced management and geological teams, Metals Creek Resources Ltd. could be ready for a breakout. More >

This Pharmaceutical Company Has a Brilliant Concept
Source: Penny Queen  (1/17/22)
Algernon Pharmaceuticals is a clinical-stage, small biotech that boasts a massive pipeline of lower risk and efficient drugs. Catalysts abound with this genius repurposing company. More >

Hydrogen Stock at Great Entry Point
Source: Clive Maund  (1/17/22)
Following a severe downtrend, charts show Jericho Energy Ventures Inc. could be about to take off, analyst Clive Maund says. More >

Uranium Explorer Expecting Drill Results Soon
Source: The Critical Investor  (1/16/22)
The Critical Investor discusses the latest developments for Blue Sky Uranium with CEO Niko Cacos, as a new drill program at Ivana has commenced, and the company has won a lawsuit. More >

BC Junior Looks to Boost Status in Golden Triangle
Source: Streetwise Reports  (1/15/22)
If your neighbors sell their house, the sale price will tell you a lot about the value of your home. In British Columbia’s Golden Triangle, companies with mines and well-defined resource development plans are getting taken out and the remaining players — and their investors — can see the favorable writing on the wall. More >

Semiconductor Sales Forecast Third Straight Year of Growth on Tight Supplies, Global Digital Transformation
Source: McAlinden Research  (1/15/22)
After semiconductor sales shattered records in 2021 amid an ongoing supply shortage, chip manufacturers are forecasting another year of growth in 2022. An overwhelming digital transformation is expected to ramp up this year across multiple industries, which could subsequently bring over half a trillion dollars to the semiconductor industry, writes McAlinden Research Partners. More >

Lithium Mining Co. Expands Asset Portfolio in New Deal
Source: The Critical Investor  (1/14/22)
The Critical Investor provides a quick update about Argentina Lithium, after they announced the acquisition of more lithium projects, on the back of a C$6M raise. All this when lithium product prices are breaking record after record. More >

Sell-Side Research Started On Copper Mining Co.
  (1/13/22)
World Copper continues to execute its strategy of acquiring and advancing copper projects, with lots of work planned for 2022, noted a Zacks Small-Cap Research report. More >

A Critical Q & A With Kenorland Minerals CEO Zach Flood
Source: The Critical Investor  (1/13/22)
After Kenorland Minerals announced its latest batch of drill results, the Critical Investor took the opportunity to do an extensive interview with CEO Zach Flood to discuss results, programs, strategy, and projects for 2022. More >

Leading Low-Cost Homebuilder Posts 71% Increase in Q4 EPS
Source: Streetwise Reports  (1/13/22)
Shares of leading homebuilder KB Home rose 16% after the company reported Q4/21 and FY/21 financial results that included substantial increases in revenues and margins fueled by rising sales prices and demand for new homes nationwide. More >

Successful Junior Miner Sees Cash Flow
Source: Michael Sheikh  (1/13/22)
Michael Sheikh explains what makes Guanajuato Silver Co. a unique opportunity and takes a look at five other companies that caught his eye. More >

Get Ballanger's Top Picks for 2022
Source: Michael Ballanger  (1/12/22)
Sector expert Michael Ballanger finds himself at an investing crossroads. Find out what his top picks are for 2022. More >

Goliath Nails High-Grade Gold in 24 Out of 24 Holes, Stock Declines
Source: Bob Moriarty  (1/12/22)
Bob Moriarty of 321Gold shares his thoughts on Goliath Resources' outstanding drill results, which they just announced on Tuesday. More >

Progress at Several Top Resource Companies
Source: Adrian Day  (1/12/22)
In this update, Adrian Day discusses some recent developments that occurred over the holidays, or otherwise got lost in the shuffle.
More >

Ph1 Trial Results of Dementia Drug Positive
  (1/12/22)
Anavex Life Sciences' study of Anavex 3-71 in frontotemporal dementia met primary and secondary safety endpoints, noted a Dawson James Securities report. More >

Cell Firm Joins With Food Co. to Create Meat Substitute
  (1/12/22)
Pluristem Therapeutics and Tnuva will incorporate a new company that will use its own funding and resources to develop cell-based synthetic meat products, noted a Dawson James Securities report. More >

Vaccine Maker Doses 1st Patient in Phase 1b Parkinson's Trial
Source: Streetwise Reports  (1/12/22)
Shares of new class synthetic vaccine developer Vaxxinity Inc. traded 23% higher after the company reported it has dosed the first patient in its Phase 1b UB-312 Parkinson's disease study. More >

Newrange Expands Gold Search in 2022
Source: Streetwise Reports  (1/11/22)
Newrange Gold Corp. is expanding its search for precious minerals from one project to three in 2022 and looking at the big picture at its flagship operation in Nevada. More >

Media Co. Gets New Listing on CSE
Source: Streetwise Reports  (1/11/22)
Mijem Newcomm Tech is going public to capitalize on the cryptocurrencies trend, given it now rewards users of its marketplace app with Bitcoin SV. More >